The improvement of infection methods can save the lives of 750,000 people annually

In a scientific study published in the journal “Lancet”, it is said that the improvement of infection methods can occur annually more than 750,000 deaths, linked to the resistance of antimicrobial agents; In countries with low and medium income. These methods include cleanliness of hands, sterilization of equipment, the acquisition of safe drinking water, effective sanitation and vaccines for children, as bacterial infections caused by the infection cause an estimated 7.7 million deaths worldwide, representing 1 in every 8 death, making it the second largest cause. Nearly 5 million people die; Due to the antibiotic resistant bacteria, the study insists that sustainable access to antibiotics is a major focus at the high -level meeting of the United Nations General Assembly in September 2024. Antimicrobial resistance says the authors say that if the world does not give precedence to work to withhold antimicrobial persons, we will see that a stated people in the number of deaths Between young people and the number is what the number has in the number of the number, the number of the world’s death between young people and the downfall of the number that has the number of the number of global deaths has chronic illnesses, or they have to undergo health care or more serious operations. Professor “Irooka Okiki” of the University of iPadan, Nigeria, emphasizes the importance of patients around the world, adding that “without achieving it, the United Nations goals for sustainable development over the child and aging are at risk.” Effective antibiotics work to extend life, reduce disabilities, reduce healthcare costs and to allow medical procedures such as surgery. However, antimicrobial resistance is great and worsened by the inappropriate use of antibiotics, which threatens modern medicine, causes preventive deaths and diseases. Antimicrobial resistance and the study found that 7.7 million deaths in 2019 were due to another bacterial infection than tuberculosis, with approximately 5 million cases associated with the resistance of bacterial antimicrobials, and 1.3 million deaths directly caused by the causes of antibiotic -resistant diseases. The study highlights the exposure of infants, children, the elderly and those with chronic illnesses to resist antimicrobial agents; Due to the high risk of bacterial infection, antimicrobial resistance poses a major threat to the survival of newborns, as infection in a third of the newborns in the world causes the world. Elderly and those with chronic illnesses are also exposed to a major risk due to the resistance of antimicrobial agents, especially in hospitals and long -term care facilities, and the study says that antimicrobial resistance threatens the integrity of general medical procedures such as organ transplantation, joint replacement, chemotherapy for cancer and chronic illness. According to the co -author, Professor “Joseph Leonard” of the University of California, Berkeley, “which focuses on effective interventions installed in infection prevention, should be the core of the global action to treat antimicrobial resistance … and prevent infection from reducing the use of antibiotics, and the pressure pressure reduces the medicine.” The improvement of infection prevention estimates the analysis of the new modeling conducted for this study; The current infection prevention methods can occur annually 750,000 deaths associated with antimicrobial resistance infection. The study states that improving and combating infection prevention in healthcare facilities, including improving hands and sterilization of equipment, can save the lives of up to 337,000 people annually, and that everyone gets safe drinking water, and effective sanitation in societal environments can prevent about 247,800 deaths annually. The study confirms that the expansion of the spread of some children’s vaccines, such as lung hooks that help protect pneumonia and meningitis, and the introduction of new vaccines, such as breathing spoilage for pregnant mothers, can save the lives of 181,500 people annually. The results of the researchers emphasize how to give priority to public health procedures; To prevent infection mainly as a strategy to treat antimicrobial resistance because these methods can significantly reduce the number of deaths caused by antimicrobial resistance. The analysis also confirms that the focus on improving infection methods, water, sanitation and vaccination in low and medium income countries; The number of deaths associated with antimicrobial resistance can reduce 10% by 2030. The use of antibiotics also examines the study in evidence that occurs the prevalence of resistance in bacteria, as well as to prevent infection in the first place, and it is believed to reduce the use of antibiotics when the benefit of patients is limited to this selective pressure. There is a need to reconsider the investment in the field of antibiotic development, and the participating author, Dr. Ursula Thuratbag, from the center of anti -infection factors in Vienna, says: “We need to see a complete reflection on how we handle the discovery and development of new antibiotics with a focus on innovation and the ability to afford costs and afford sustainable costs.” The increasing number of bacterial infections indicates that any available antibiotics are no longer responding; To the urgent need to invest in antibiotics, vaccines, new diagnostic tests and ensure access to the world. The study states that the traditional model for the development of medicines, which depends on the possibility of reaching high profits to stimulate investment, does not succeed for antibiotics. Most new antibiotics are not registered in countries with low and medium income, but even if registered, it will probably be inevitable. The public sector finance the authors says that the new models funded by the public sector to develop antibiotics based on public and private sector partnerships can increase the amount of new alternatives, as well as reduce the direct costs of patients, making it easier to achieve. They also claim that they increase funding for antimicrobial resistance programs in general, as the financing of antimicrobial resistance is dramatic of diseases with less burdens, such as HIV, malaria and tuberculosis. Antimicrobial resistance will be taken for the second time at a high -level meeting, as part of the next General Assembly of the United Nations in September 2024, the study proposes ambitious and investigative world objectives for 2030, which according to writers must be adopted during the meeting within the framework of comprehensive access to antibiotics. These goals include: reducing the deaths caused by antimicrobial resistance by 10%, by expanding the extent of public health interventions to prevent infection in the first place, reducing the use of antibiotics, providing resistance and providing them more. It also contains a 20% reduction in the inappropriate use of human antibiotics by reducing the use of antibiotics to treat mild respiratory infections that do not require antibiotics in general; With a 30% decrease in the inappropriate use of animal -antibiotics by taking gradual measures in many sectors. The study also asks that an independent scientific body is concerned with the achievement of antimicrobial agents, and the resistance of expanding the basis of evidence to implement policies and directs new goals. The study provides clear guidelines based on how to reach an investigative targets that save lives, reduce antimicrobial resistance and improve food security.